Skip to ContentSkip to Navigation
About us Latest news News News articles

Advanced glycation end-products in chronic heart failure

16 May 2011

PhD ceremony: Ms. S. Willemsen, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen

Title: Advanced glycation end-products in chronic heart failure

Promotor(s): prof. A.A. Voors, prof. D.J. van Veldhuisen

Faculty: Medical Sciences

 

The number of patients with chronic heart failure (HF) is increasing. HF is a functional cardiac disorder, impairing the ability of the ventricle to fill with or eject blood combined with symptoms of fatigue and/or breathlessness. The prognosis and quality of life are poor. In this thesis the potential role of advanced glycation end-products (AGEs; glycated proteins) accumulation in the development and progression of HF was studied. AGEs accumulate during ageing and form collagen cross links, causing stiffening of heart and vessels.

The main findings are 1) Higher levels of AGEs are associated with diastolic dysfunction; 2) Elevated AGEs levels are related to the severity of HF and its clinical outcome; 3) When used in patients with systolic HF the AGE-breaker alagebrium showed no improvement on either the exercise capacity or cardiac function. Furthermore, no changes in AGE levels were observed in the blood.

 

Last modified:13 March 2020 01.12 a.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 24 March 2025

    UG 28th in World's Most International Universities 2025 rankings

    The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...

  • 05 March 2025

    Women in Science

    The UG celebrates International Women’s Day with a special photo series: Women in Science.

  • 28 February 2025

    Vici grants for two UG/UMCG scientists

    The Dutch Research Council (NWO) has awarded Vici grants, worth up to €1.5 million each, to Merel Keijzer and Charalampos Tsoumpas This will enable the researchers to develop an innovative line of research and set up their own research group for...